Fig. 2
From: Comparison of the source and prognostic utility of cfDNA in trauma and sepsis
Investigations into the potential sources of cfDNA. a Necrosis as quantified by levels of cyclophilin A. b Apoptosis as quantified by ccK18 fragments. c Day 1 MPO levels in sepsis, trauma, and healthy controls. d Correlation between myeloperoxidase (MPO) and cell-free DNA (cfDNA) in trauma patients. e Correlation between MPO and cfDNA levels in septic patients. f Levels of citrullinated histone H3 in sepsis, trauma, healthy controls. Note: ***p < 0.001, **p < 0.01; data represent median and interquartile range